Clinical Trial Update: Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating protective efficacy of different strengths of a human rotavirus vaccine administered as 2 doses to two-month-old infants; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• GlaxoSmithKline Rotavirus Vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 2 | Status: COMPLETED